PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   

Product Order number / Unit

9716 DOTA-NOC acetate (GMP) 9716.0000.06: 60 μg per vial
9716.0000.10: 100 μg per vial
9716.0000.25: 250 μg per vial
9716.0001: 1 mg per vial
Please inquire for customized filling and bulk quantities.

Precursor for radiolabelled DOTA-NOC
Ligand for somatostatin receptors
Manufactured according to GMP requirements for APIs for use in clinical trials (ICH Q7 chapter 19)
Molar Mass: 1455.7
[619300-53-7] (net peptide)
Colourless to off-white solid packaged in plastic vials
Purity: > 98 % (9716.0001)
> 97 % (9716.0000.06 9716.0000.10 9716.0000.25)
CoA with ESI-MS (identity); HPLC (purity); GC (residual solvents, acetate content, water content); heavy metal content (ICP-MS)
Chemical Name:
Sequence: DOTA-D-Phe-Cys-Nal-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide Cys2,7
DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-
Nal = 3-(1-naphthalenyl )-L-alanyl
Supplied as acetate salt
DOTA-[Nal3]-octreotide; CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)- L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Same as product number 9712.
date of product catalogue issue: 10 May 2017


  PDF file       product list       home page       search       email       legal notice